Atlas Trials

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Clinical trial NCT02512588 · COMPLETED

Trial details

NCT number
NCT02512588
Sponsor
Balance Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Start date
2015-09-01
Primary completion
2018-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.